Tuesday, January 18, 2011 11:12:35 AM
What: Santarus Analyst Day and Investor Briefing
When: Wednesday, January 19, 2011 at 4:15 p.m. Eastern time
Where: www.santarus.com (under the Investor Relations link)
AGENDA
* Strategic Overview and 2011 Financial Outlook
* CYCLOSET® - Clinical/Medical Background
* ULTESA™ (Budesonide MMX®) – Overview and Top-line Phase III Clinical Study Results
* Ulcerative Colitis – Treatment Perspective
* RHUCIN® and Hereditary Angioedema (HAE)
* SAN-300 (anti-VLA-1 antibody)
* Wrap-up/Question & Answer Session
How: Live over the Internet – Simply log on to the Investor Relations section of the company's website at www.santarus.com
Contact:
Lippert/Heilshorn & Associates
Narine Darbinyan
310-691-7100
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM